Advanced search

Development of an S-G2 micronucleus assay for the detection of in vitro chromosomal radiosensitivity in high-risk women subjected to early mammography screening for breast cancer

Anne Vral (UGent) , Julie Depuydt (UGent) , Annelot Baert (UGent) , Bruce Poppe (UGent) , Tom Van Maerken (UGent) , Fransiska Malfait (UGent) , Kim De Leeneer (UGent) , Marc D'Hooghe and Kathleen Claes (UGent)
Author
Organization
Abstract
Ionizing radiation induces DNA double-strand breaks (DSB). The two major repair pathways for DSB are homologous recombination (HR), operating only in late S and G2 phase, and non-homologous end joining (NHEJ), active throughout the whole cell cycle. It is known that the micronucleus (MN) assay, based on irradiation of cells in the G0 phase of the cycle cannot unequivocally detect enhanced radiosensitivity in carriers of BRCA1 and BRCA2 mutations. This is mostly due to the fact that breast cancer susceptibility genes such as BRCA1, BRCA2 and ATM are mainly involved in the G2-phase specific HR pathway and/or in the G2/M checkpoint control. To increase sensitivity of the micronucleus assay in detecting defects in these specific pathways, we designed a modified S-G2-micronucleus assay allowing detection of defects in HR and G2/M cell cycle control. Such assay may not only serve for assessing radiosensitivity in women with a proven or presumed genetic predisposition for breast cancer, but may also be a useful tool for phenotypical diagnosis of inherited genome instability diseases. Preliminary results obtained with the S-G2 micronucleus assay in a family of a patient with variant Ataxia-Telangectasia and in a pilot group of BRCA1 +/- mutation carriers are very promising and will be presented. With the new S-G2 micronucleus assay significantly increased radiation-induced MN yields were obtained in mutation carriers compared to healthy controls. When applied to BRCA1/2 mutation carriers on a broad scale and in the frame of a large population study (in progress), the results of the novel assay may aid to establish whether benefits from early mammographic screening in asymptomatic women with a family history of breast cancer are likely to outweigh the risks linked to increased cumulative doses of radiation.

Citation

Please use this url to cite or link to this publication:

Chicago
Vral, Anne, Julie Depuydt, Annelot Baert, Bruce Poppe, Tom Van Maerken, Fransiska Malfait, Kim De Leeneer, Marc D’Hooghe, and Kathleen Claes. 2013. “Development of an S-G2 Micronucleus Assay for the Detection of in Vitro Chromosomal Radiosensitivity in High-risk Women Subjected to Early Mammography Screening for Breast Cancer.” In International Journal of Molecular Medicine, 32:S51–S51.
APA
Vral, A., Depuydt, J., Baert, A., Poppe, B., Van Maerken, T., Malfait, F., De Leeneer, K., et al. (2013). Development of an S-G2 micronucleus assay for the detection of in vitro chromosomal radiosensitivity in high-risk women subjected to early mammography screening for breast cancer. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (Vol. 32, pp. S51–S51). Presented at the 18th World congress on Advances in Oncology ; 16th International symposium on Molecular Medicine.
Vancouver
1.
Vral A, Depuydt J, Baert A, Poppe B, Van Maerken T, Malfait F, et al. Development of an S-G2 micronucleus assay for the detection of in vitro chromosomal radiosensitivity in high-risk women subjected to early mammography screening for breast cancer. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2013. p. S51–S51.
MLA
Vral, Anne, Julie Depuydt, Annelot Baert, et al. “Development of an S-G2 Micronucleus Assay for the Detection of in Vitro Chromosomal Radiosensitivity in High-risk Women Subjected to Early Mammography Screening for Breast Cancer.” International Journal of Molecular Medicine. Vol. 32. 2013. S51–S51. Print.
@inproceedings{4236078,
  abstract     = {Ionizing radiation induces DNA double-strand breaks (DSB). The two major repair pathways for DSB are homologous recombination (HR), operating only in late S and G2 phase, and non-homologous end joining (NHEJ), active throughout the whole cell cycle. It is known that the micronucleus (MN) assay, based on irradiation of cells in the G0 phase of the cycle cannot unequivocally detect enhanced radiosensitivity in carriers of BRCA1 and BRCA2 mutations. This is mostly due to the fact that breast cancer susceptibility genes such as BRCA1, BRCA2 and ATM  are mainly involved in the G2-phase specific HR pathway and/or in the G2/M checkpoint control. To increase sensitivity of the micronucleus assay in detecting defects in these specific pathways, we designed a modified S-G2-micronucleus assay allowing detection of defects in HR and G2/M cell cycle control. Such assay may not only serve for assessing radiosensitivity in women with a proven or presumed genetic predisposition for breast cancer, but may also be a useful tool for phenotypical diagnosis of inherited genome instability diseases.
Preliminary results obtained with the S-G2 micronucleus assay in a family of a patient with variant Ataxia-Telangectasia and in a pilot group of BRCA1 +/- mutation carriers are very promising and will be presented. With the new S-G2 micronucleus assay significantly increased radiation-induced MN yields were obtained in mutation carriers compared to healthy controls.
When applied to BRCA1/2 mutation carriers on a broad scale and in the frame of a large population study (in progress), the results of the novel assay may aid to establish whether benefits from early mammographic screening in asymptomatic women with a family history of breast cancer are likely to outweigh the risks linked to increased cumulative doses of radiation.},
  articleno    = {abstract 287},
  author       = {Vral, Anne and Depuydt, Julie and Baert, Annelot and Poppe, Bruce and Van Maerken, Tom and Malfait, Fransiska and De Leeneer, Kim and D'Hooghe, Marc and Claes, Kathleen},
  booktitle    = {INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE},
  issn         = {1107-3756},
  language     = {eng},
  location     = {Hersonissos, Greece},
  number       = {suppl. 1},
  pages        = {abstract 287:S51--abstract 287:S51},
  title        = {Development of an S-G2 micronucleus assay for the detection of in vitro chromosomal radiosensitivity in high-risk women subjected to early mammography screening for breast cancer},
  volume       = {32},
  year         = {2013},
}

Web of Science
Times cited: